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Background/Aims: The aim of this study was to investigate the dose-
response effect of lactoferrin (Lf) intervention on gene expression in the
hippocampus of postnatal piglets during neurodevelopment.
Methods: Fifty-one 3-day-old piglets were randomly allocated into a high
(H) Lf dose group (n ¼ 18), a low (L) Lf dose group (n ¼ 17) and a control (C)
group (n ¼ 16). Piglets were fed sow milk replacer supplemented with Lf at
285 mg/kg/d (H), 155 mg/kg/d (L) and 16 mg/kg/day (C). Piglets were
euthanized at 38 days of age. RNA transcript proﬁling in the hippocampus
was carried out using RNA isolated from 10 piglets/gp on Porcine Affyme-
trix. A TaqMan® Gene expression assay based on qPCR was used to validate
the microarray ﬁndings. The results were analyzed using the Partek Ge-
nomics Suite 6.5 software and Ingenuity System.
Results: Low-dose Lf activated neurotrophin signalling pathways and
modulated expression of genes associated with neurodevelopment,
learning & memory, including BDNF, FGFR, IRS1 and CAMKK1. Functional
analysis showed network signalling impacted brain development, neuron
structure and long-term potentiation. In contrast, piglets on the high dose
of Lf showed no effect on neurotrophin signalling but an increase in gene
expression and signalling pathways leading to cell death/apoptosis and
decreased neurogenesis.
Conclusions: Low-dose Lf supplementation up-regulated neurotrophin
signalling pathways associated with neurodevelopment and cognition, a
ﬁnding in contrast to piglets on a high dose of Lf. The molecular mecha-
nism(s) underling this paradoxical ﬁnding remains under study.
Funding source(s): Medical School, Xiamen University & Nestle Research
Centre, Beijing.
CONCURRENT SESSION 2: LIPIDS.
POSTPRANDIAL TRIGLYCERIDES RESPONSE TO KRILL OIL
SUPPLEMENTATION IN HEALTHY WOMEN
H. Sung 1, A. Sinclair 2, P. Lewandowski 2, X. Su 1. 1College of Health and
Biomedicine, Victoria University, Melbourne, Australia; 2 School of Medicine,
Deakin University, Victoria, Australia
E-mail address: teetree86@gmail.com (H. Sung)
Background: Krill oil (KO) has been suggested to have higher bioavail-
ability of EPA and DHA compared with ﬁsh oil. There are limited reports on
the postprandial effects of KO. This study investigates the impacts of
supplementation with KO and ﬁsh oil (FO) on plasma lipid proﬁles in the
postprandial state.
Methods: This is a randomised cross-over study. Test meals consisting
fresh mashed-potato and 15 g of olive oil (OO) and 5 g of with three oil
supplements (KO, FO or OO) were randomly provided on each study day
with seven days wash-out period between. Blood samples were collected
at the baseline and post consumption of test meal/supplement on hourly
basis for 5 hours. Postprandial changes were assessed using SPSS. SPA-
NOVA for repeated measure was performed to assess the changes between
the treatments. One-way ANOVA and multiple comparisons using Tukey
HSD post-hoc analysis were also performed to assess the changes in the
parameters over timewithin the treatment group. P < 0.05 was considered
statistically different.
Results: There were no signiﬁcant changes in the postprandial TAG levels
in either chylomicron or plasma between the three oil treatments (p ¼
0.783). However within the treatment groups, changes in TAG with time
after oil consumption were signiﬁcantly different (p < 0.001) and the
magnitude of changes varies in each treatment.
Conclusions: Therewere no signiﬁcant difference in the absorption of TAG
in chylomicron or plasma between FO and KO. Since KO contains n-3 fatty
acids in phospholipids, n-3 proﬁle in postprandial plasma phospholipidshould be examined.
Funding source(s): College of Health and Biomedicine, Victoria University,
Melbourne, Australia.
WHY ARE FISH OIL SUPPLEMENTS APPARENTLY FAILING TO
REPRODUCE FISH CONSUMPTION EPIDEMIOLOGY IN RCT FOR
CARDIOVASCULAR DISEASE?
P. McLennan 1, G.E. Peoples 1, M.J. Macartney 1, S.K. Venoe 2. 1Graduate
School of Medicine, University of Wollongong, NSW, Australia; 2 Faculty of
Medicine, Aalborg University, Aalborg, Denmark
E-mail address: petermcl@uow.edu.au (P. McLennan)
Background/Aims: Regular ﬁsh consumption is associated with low car-
diovascular disease risk. However, randomised control trials (RCT) of ﬁsh
oil supplements produce variable results, recently interpreted to no longer
support beneﬁcial effects of long chain n-3 polyunsaturated fatty acids
(LCn-3PUFA) EPA and DHA in treating or preventing cardiovascular
disease.
Methods: This review considers issues key to understanding the
contradiction.
Results: 1) Most RCT report no exclusion criteria for ﬁsh eaters and fewer
analyse n-3 PUFA status. Even in RCT with exclusions overlap of tissue n-3
PUFA status remain between control and treated groups. 2) Cardiac effects
(sudden death, heart failure) derive from myocardial membrane incor-
poration of DHA. The LCn-3PUFA intake in cohort studies derives from
seafood, providing more DHA than EPA, whereas most RCT use supple-
ments rich in EPA, low in DHA. 3) Nutritional and therapeutic effects of
LCn-3PUFA derive from direct and indirect mechanisms. Effects on heart
rate, heart failure and sudden death occur at lower intakes than inﬂuence
classical coronary artery disease risk factors such as hypertriglyceridaemia.
RCT designs combining cardiac and arterial disease populations and
composite endpoints propose a common substrate and assume common
mechanisms of action.
Conclusions: Many ﬁsh oil RCT included in systematic reviews are
methodologically unsound, failing to consider background diet and mul-
tiple mechanisms of LCn-3PUFA or clinical disease Mechanisms of action
must be better understood and RCT design and analysis improved to
resolve apparent contradictory effects of LCn-3 PUFA supplements and
eating ﬁsh.
Funding source(s): N/A.
DAILY VS. WEEKLY ADMINISTRATION OF FISH OIL: BIOAVAILABILITY
AND EFFICIENCY OF DIETARY LONG CHAIN OMEGA-3 FATTY ACIDS
S. Ghasemifard 1, A.J. Sinclair 1, P. Lewandowski 1, G.M. Turchini 2. 1 School of
Medicine, Deakin University, VIC, Australia; 2 School of Life and
Environmental Sciences, Deakin University, VIC, Australia
E-mail address: samane.ghasemifard@gmail.com (S. Ghasemifard)
Background/Aims: The recommendations on the intake of long chain
omega-3 polyunsaturated fatty acids (n-3 LC-PUFA) vary from eating oily
ﬁsh (‘once to twice/week’) to consuming speciﬁed daily amounts of EPA
and DHA (‘250e500 mg/day’). It is not known if there is a difference in
the uptake/bioavailability between these two feeding strategies. In this
study, the bioavailability of a daily dose of n-3 LC-PUFA (Constant treat-
ment) versus a large weekly dose of n-3 LC-PUFA (Spike treatment) was
assessed.
Methods: Six-week old male Sprague-Dawley rats were fed either a
Constant, a Spike or Control treatment (no n-3 LC-PUFA), for six weeks. The
whole body, tissues and collected faeces were analysed for fatty acid
content.
Results: The results showed that the major metabolic fate of the n-3 LC-
PUFA was towards catabolism (b-oxidation) accounting for over 70% of
total dietary intake, whereas deposition accounted less than 25% of total
dietary intake. It was found that signiﬁcantly more n-3 LC-PUFA were b-
oxidised when originating from the Constant treatment (84% of dose),
compared with the Spike treatment (75% of dose). Conversely, it was found
that signiﬁcantlymore n-3 LC-PUFAwere depositedwhen originating from
the Spike treatment (23% of dose), than from the Constant treatment (15%
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Conclusions: These unexpected ﬁndings show that a large dose of n-3 LC-
PUFA once per week is more effective in increasing whole body n-3 LC-
PUFA content compared with a smaller dose delivered daily.
Funding source(s): The Molecular Medicine Strategic Research Centre,
Deakin University.
SATURATED FAT ENHANCES INCORPORATION OF N-3
POLYUNSATURATED FATTY ACIDS INTO PLASMA AND ERYTHROCYTE
LIPIDS IN HEALTHY HUMANS
C.B. Dias 1,2, L.G. Wood 2, M.L. Garg 1,2. 1Nutraceuticals Research Group,
University of Newcastle, NSW, Australia; 2 School of Biomedical Sciences &
Pharmacy, University of Newcastle, NSW, Australia
E-mail address: cintia.dias@uon.edu.au (C.B. Dias)
Background/Aims: High fat meals have been previously shown to pro-
mote bioavailability of n-3 polyunsaturated fatty acids (n-3PUFA). While
the effect of dietary fat types on incorporation of n-3PUFA into blood and
tissue lipids has been widely discussed in the literature, to-date this
phenomenon has not been reported in humans.
Methods: This was a randomised, controlled, parallel, dietary interven-
tion trial involving 25 healthy adults aged 18 to 65 years. Subjects
consumed foods rich in either saturated (SFA) or n-6 polyunsaturated
fatty acids (n-6PUFA), all supplemented with 2.4 g n-3PUFA daily for 6
weeks. Blood samples were collected after an overnight fast, at baseline
and post-intervention, for analysis of plasma and red blood cell fatty
acids.
Results: Linoleic acid increased signiﬁcantly in plasma but not erythro-
cytes following the n-6PUFA diet, and did not change after the SFA diet.
There was an increase in eicosapentaenoic acid (EPA) which was signiﬁ-
cantly higher (2 fold) after the SFA compared to the n-6PUFA diet. There
was also a greater increase in docosahexaenoic acid (DHA) after the SFA
diet, although this was not signiﬁcantly different to the n-6PUFA diet.
Conversely there was a signiﬁcant reduction in plasma docosapentaenoic
acid (DPA) which was 2 fold greater following the n-6PUFA compared to
the SFA diet.
Conclusions: Dietary background fat type affects n-3PUFA incorporation
into plasma and erythrocytes in healthy subjects. Dietary SFA facilitate n-
3PUFA incorporation into plasma and erythrocytes compared to dietary n-
6PUFA.
Funding source(s): Hunter Medical Research Institute (HMRI) and Coor-
denaç~ao Nacional de Desenvolvimento Cientíﬁco e Tecnologico (CNPq,
Brazil).THE EFFECT OF LONG CHAIN OMEGA 3 PUFA ON RESTING AND
RECOVERY HEART RATE IN HEALTHY ADULTS
B. Isip, E. Neale, G. Peoples, L. Tapsell. University of Wollongong, NSW,
Australia
E-mail address: bi983@uowmail.edu.au (B. Isip)
Background/Aims: An elevated heart rate at rest and slower recovery
following exercise are indicators of cardiovascular disease (CVD) mortality
and death. Research suggests consumption of long chain omega-3 poly-
unsaturated fatty acids (LCn-3PUFA) have an anti-arrhythmic effect on the
heart and reduce heart rate in those with cardiovascular dysfunction. This
systematic literature review aimed to investigate the current evidence
regarding the effects of LCn-3PUFA on resting and recovery heart rate in
adults free from CVD.
Methods: A systematic search of the databases Scopus, Web of Science
and the Cochrane Library was conducted (January 2005 to May 2015).
Inclusion criteria were: randomised controlled trials investigating the
effect of LCn-3PUFA consumption on resting and/or recovery heart rate in
healthy adults without pre-existing CVD. Studies were assessed for
quality using the American Dietetic Association Quality Criteria
Checklist.
Results: Of the eight articles identiﬁed in this review, only two showed a
heart rate lowering effect of LCn-3PUFA consumption. These two studiesinvolved participants with elevated resting heart rates or risk factors for
CVD. Recovery heart rate was assessed in only one study, which found a
reduction following LCn-3PUFA consumption.
Conclusions:Whilst a lack of an effect of LCn-3PUFA on resting heart rate
was found in most studies, supplementation with LCn-3PUFA appeared to
be effective in individuals with elevated resting heart rates. Further studies
are needed to determine these effects on heart rate recovery in healthy
adults.
Funding source(s): N/A.
N-6 POLYUNSATURATED FATTY ACID INTAKE AND RISK OF MORTALITY
IN THE AUSDIAB COHORT
A.J. Owen 1, D.J. Magliano 1,2, K. O'Dea 3, E.L.M. Barr 2, J. Shaw 2. 1Monash
University, VIC, Australia; 2Baker IDI Heart & Diabetes Institute,
Melbourne, VIC, Australia; 3 Sansom Institute for Health Research, Adelaide,
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Background/Aims: Analysis of the Sydney Heart Study reported an
adverse effect of dietary n-6 polyunsaturated fatty acids (PUFA) on mor-
tality, and recent meta-analyses have reached contrasting conclusions
regarding the effect of dietary n-6 polyunsaturated fatty acids (PUFA) on
cardiovascular mortality. The aim of this study was to examine the effect of
n-6 PUFA on mortality in the Australian Diabetes, Obesity and Lifestyle
Study (AusDiab) cohort, a large Australian prospective study of cardio-
metabolic health.
Methods: The relationship between dietary PUFA intake and all-cause or
CVD mortality in the AusDiab cohort, a population of 11,247 Australians
aged 25 y recruited in 1999/2000 and followed until 2012, was examined
using Cox regression. Comorbidities, demographic, and lifestyle informa-
tion was collected by questionnaire, and fasting blood tests undertaken.
Baseline dietary intake was assessed by a 121-item food frequency ques-
tionnaire. Vital status and causes of death were collected by linkage to
death registries.
Results: Adjusted for age and sex, those in the highest quintile of n-6 PUFA
intake had lower risk of total and cardiovascular mortality (all-cause
mortality HR: 0.82, 95% CI: 0.69-0.99, p <0.05), but this failed to retain
signiﬁcance after further adjustment for previous cardiovascular disease,
education, exercise, diabetes, dietary energy and smoking.
Conclusions: These ﬁndings from a contemporary Australian cohort sug-
gest that n-6 PUFA have neutral or possibly beneﬁcial effects on all-cause
and cardiovascular mortality.
Funding source(s): None to declare for these analyses. However AusDiab
has been funded by NHMRC, as well as support from State governments,
academic and industry bodies.
CONCURRENT SESSION 3: CARBOHYDRATES.
THE EFFECT OF IMPROVING DIETARY QUALITY ON MEASURES OF
VASCULAR STRUCTURE AND FUNCTION IN A POPULATION WITH
DIABETES
K.S. Petersen, J.B. Keogh, N. Blanch, P.M. Clifton. School of Pharmacy and
Medical Sciences, University of South Australia, SA, Australia
E-mail address: kristina.petersen@mymail.unisa.edu.au (K.S. Petersen)
Background/Aims: People with diabetes have a heightened risk of
cardiovascular disease compared with the general population. The aim
was to determine if increasing fruit (+1 serving), vegetable (+2 servings)
and dairy (+1 serving) intake slows 12 month common carotid artery
intima media thickness (CCA-IMT) progression, compared to a control
group continuing on their usual diet, in people with type 1 and type 2
diabetes. Secondary outcome measures were peripheral and central
blood pressure, augmentation index (AI) and pulse wave velocity
(PWV).
Methods: A 12 month randomised controlled trial was conducted. The
primary outcome was mean CCA-IMT, measured at baseline and 12
months using B mode ultrasound. Secondary outcomes were peripheral
and central blood pressure, AI and PWV, measured at baseline, 3, 6, 9 and
12 months. Participants in the intervention group received dietary
